Explore the NACFC Mobile App Menu

The Cystic Fibrosis Foundation is excited to announce three great topics for the multi-disciplinary Plenary sessions.  One Plenary will be presented each day (Thursday, Friday, and Saturday) at NACFC 2018.
Following are the current topics and speakers for the three Plenaries.

Plenary 1

Improving Outcomes of Infections in the Age of CFTR Modulators

Lisa Saiman, M.D., M.P.H.

About Dr. Saiman:  
Dr. Saiman is a professor of pediatrics at Columbia University Medical Center and an attending physician at New York-Presbyterian Morgan Stanley Children’s Hospital, where she has served as the hospital epidemiologist since 1992. Dr. Saiman’s primary research and clinical interests are the infectious disease and microbiology issues in people with CF and healthcare-acquired infections, multidrug-resistant pathogens, and antimicrobial stewardship. She was the co-chair of the 2003 and 2013 Guidelines for Infection Control and Prevention in CF.

Session Description:  
In this session, Dr. Lisa Saiman will address the challenges of infections in people with CF and discuss why infections remain a major focus of the CF community, even in the era of effective CFTR modulators.  She will provide an overview of CF infections, describe ongoing studies to increase our understanding of CF microorganisms and their optimal treatment, and discuss current strategies to develop new anti-infective agents to treat even the most difficult infections.

Plenary 2

Anti-inflammatories & Mucociliary Clearance Therapies in the Age of CFTR Modulators

Felix Ratjen, M.D., Ph.D.

About Dr. Ratjen:  
Dr. Ratjen is the division chief of paediatric respiratory medicine at the Hospital for Sick Children in Toronto. He serves as a professor of paediatrics at the University of Toronto, and program head and senior scientist at the Research Institute in the Department of Translational Medicine. Dr. Ratjen holds the H.E. Sellers chair in CF at the Hospital for Sick Children. His research interests include early intervention strategies in paediatric lung diseases and physiological tests to assess early lung disease, with a particular focus on CF lung disease. Dr. Ratjen has conducted multiple clinical trials addressing various aspects of CF including the treatment of airway infections and airway inflammations, as well as new therapeutic strategies.

Session Description: 

This plenary will review the effect of CFTR dysfunction and CFTR restoration on both inflammation and mucociliary clearance in individuals with CF.  Current and future therapeutic strategies to address inflammation and mucociliary clearance will be discussed, as well as how these strategies have potential to benefit both those patients using CFTR modulators and those not eligible for modulators.

Plenary 3

Partnering: The Oldest New Idea to Improve CF Care

Maren Batalden, M.D., M.P.H.

Kathryn Sabadosa, M.P.H.
Melanie Abdelnour, CF Advisory Board
Cynthia George, M.S.N., F.N.P., CF Foundation

About Dr. Batalden:  
Dr. Batalden is associate chief quality officer, associate director of graduate medical education for quality and safety, and director of medical management within the Accountable Care Organization at the Cambridge Health Alliance in Cambridge, MA.  Dr. Batalden provides leadership for improvement initiatives in the domains of inpatient care, care transitions, and cross continuum population health projects for patients with chronic disease.  She is clinically active as a hospitalist and is engaged in teaching quality, safety and systems improvement to undergraduate, graduate, and mid-career health professionals.  In all of her work – as a practicing clinician, as an educator, and as a leader of institutional change projects, she is interested in using the lens of co-production to catalyze more effective partnership between patients and health professionals. Dr. Batalden also is an assistant professor in medicine at Harvard Medical School.

Session Description:  
Central to the management of CF are the relationships that people with CF and their families build with their clinical care teams. As people with CF live longer, their disease increases in complexity, making coordination and individualized care ever more dependent upon these foundational relationships. Actively partnering in health care is a learning process and although, highly regarded, realizing and maintaining full partnership can be challenging. This plenary will walk through the evolution of partnering, specifically in CF care and more broadly in the context of health care and society, further thinking by exploring the tensions impacting partnership, and highlight new strategies supported by the CF Foundation, so that all people living with CF can better balance their daily care while attaining personal goals. The plenary will end with a panel discussion between an adult living with CF, a parent, and a healthcare professional from the CF Foundation.

In-page image